GETTING GROWING / THE ANSWER / 30 SEPT 2026 / 4 MIN READ
Should your agency tell prospects what it can't do?
Yes. In new UK buyer research, 41% said an honest discussion of limitations strengthens their confidence in a supplier, and 40% named inflated claims without proof as the single biggest trust-killer.
Yes - buyers read candour about your limits as evidence that the rest of your claims are true, and inflated claims are the fastest way to lose a pitch you were capable of winning.
That runs against pitch instinct, which treats every gap as a liability and every question as one to answer with a yes. The latest buyer research suggests the instinct costs agencies more than it protects.
What the new research found
The Trust Advantage 2026, from Emmett & Churchman and reported by PRmoment on 24 September, surveyed 200 UK senior technology decision-makers and ran 19 in-depth interviews with senior business leaders. It set out to explain why capable suppliers lose deals they should win.
Two findings answer this question directly. Forty-one percent said a clear, honest discussion of limitations, risks and trade-offs actually strengthens their confidence in a supplier. And 40% named inflated claims without proof as the single biggest way to kill trust, ahead of inconsistent messaging and evasive answers.
The rest of the data describes the market those two findings sit in. Forty-five percent say many capable suppliers fail because they struggle to prove their credibility. Nineteen percent say capable suppliers never make the shortlist because buyers don't know enough about them. And 57% are likely or very likely to choose a lesser-known supplier over an incumbent if they trust the challenger more.
Why tech-buyer data applies to agency buying
The sample is B2B technology buyers, not marketing directors, and it is worth being precise about that. Nobody surveyed here was appointing an agency.
The finding transfers because the purchase has the same structure. A technology buyer and a marketing director are both committing budget to a supplier whose output cannot be inspected in advance. Both are buying a promise about future performance, made by the people who will be paid to deliver it. Both have to defend the decision internally if it goes wrong. Those are the conditions under which trust decides the outcome, and they apply to an agency appointment at least as strongly as to a software contract, because in an agency the product is largely the people doing the pitching.
Where the analogy is weakest, it cuts in the agency's favour. Technology comes with specifications a buyer can check. Agency capability mostly does not, which puts even more weight on whether the claims sound calibrated.
What candour signals to the buyer
A buyer in a pitch is running a quiet calibration exercise. Every claim you make is weighed against how likely you are to be telling them what they want to hear.
An agency that says yes to everything gives them no reference point. Every claim carries the same weight, and the easiest assumption is that all of them are inflated. An agency that says it is strong in one area, adequate in another, and would bring in a partner for a third has handed the buyer a scale to read everything else against.
The limit you name in the pitch is what makes the rest of your claims believable.It also answers a question the buyer was going to ask anyway. Experienced marketing directors know where agency capabilities thin out. Hearing it from you first is a demonstration of judgement. Discovering it in month three is a breach of trust, and it colours every conversation after it.
Where agencies get this wrong
There are two failure modes, and they point in opposite directions.
The common one is the overclaim. The integrated offer that is really two specialists and a freelancer. The data capability that is one analyst. The sector experience that amounts to a single project several years ago. These survive the credentials deck and fall apart in the chemistry meeting, when the buyer asks a second question and the answer gets vague. That is the 40% finding in practice.
The rarer one is the apologetic disclosure. Candour works when it is specific and arrives with a plan attached. Saying the agency does not run paid social in-house, then naming who it would bring in and how the handover works, builds confidence. A hedged, general admission that the agency is small or still building something reads as a lack of conviction. The research describes a discussion of limitations, risks and trade-offs, which implies substance on the other side of the admission.
How to decide what to say
The useful line is between limits that matter to this brief and limits that don't. A gap outside the scope is worth naming in passing, because it shows you understand the edges of what you do. A gap inside the scope has to be named with the answer attached, or it becomes the question the buyer's colleagues raise after you have left the room.
What should never survive into a pitch is a claim you would be uncomfortable being tested on. If the team would hesitate when asked for the evidence, the claim is doing more harm than the gap it covers.
Candour in the room also depends on what the buyer found before you arrived. It only reads as confidence if the public record already supports the strengths you are claiming, which is why the checking that happens between shortlist and meeting matters so much - the argument in the credibility gap between shortlist and pitch. An agency that admits a limit in the room, having shown nothing verifiable beforehand, has told the buyer about a weakness without having established anything to set it against.
If you are working out which of your claims the market actually believes, that is where our method starts.
WRITTEN BY
Fayola Douglas, founder of They Said